UGT1A1 polymorphism predicts irinotecan toxicity: Evolving proof
Journal Title: The AAPS Journal - Year 2001, Vol 3, Issue 3
Abstract
Authors and Affiliations
Sridhar Mani
Keywords
Related Articles
- EP ID EP682054
- DOI 10.1208/ps0303_commentary2
- Views 82
- Downloads 0
Influence of fluoxetine on olanzapine pharmacokinetics
Conventional antidepressant treatment fails for up to 30% of patients with major depression. When there are concomitant psychotic symptoms, response rates are even worse. Thus, subsequent treatment often includes combina...
Use of anatomical and kinetic models in the evaluation of human food additive safety
Toxicological testing in animals is relied upon as a surrogate for clinical testing of most food additives. Both animal and human clinical test results are generally available for direct additives when high levels of exp...
Mapping the Target Localization and Biodistribution of Non-Radiolabeled VMAT2 Ligands in rat Brain
Imaging targeting vesicular monoamine transporter (VMAT2) alterations is a sensitive tool for early diagnosis of Parkinson’s disease. Our group has reported several novel 2-amino-DTBZ derivatives as potential VMA...
Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors
We review the effect of some key advances in the characterization of molecular mechanisms of signaling by G protein-coupled receptors (GPCRs) on our current understanding of mechanisms of drugs of abuse. These advances a...
Model-based development of gemcabene, a new lipid-altering agent
The purpose of this study was to evaluate the value of model-based, quantitative decision making during the development of gemcabene, a novel lipid-altering agent. The decisions were driven by a model of the likely clini...